WEST LAFAYETTE, Ind., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Ron Ellis, President and CEO of Endocyte, will present at the upcoming 2011 Life Sciences Management Access Conference on Wednesday, August 17, 2011 at 8:00 AM EDT. The conference is being held at Le Parker Meridien in New York.
